Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Dextromethorphan)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002283 AN003728 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire Area integration
ST001639 AN002682 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002173 AN003561 Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-Omics approach Cultured cells Human Cancer University of Sharjah AU
ST002248 AN003674 Quantitative multi-Omics analysis of paclitaxel-loaded Poly(lactide-co-glycolide) nanoparticles for identification of potential biomarkers for head and neck cancer Cultured cells Human Cancer University of Sharjah AU
ST002273 AN003715 Multi-Omics analysis revealed a significant alteration of critical metabolic pathways due to sorafenib-resistance in Hep3B cell lines Cultured cells Human Cancer Sharjah Institute for Medical Research AU
ST002447 AN003988 Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals Pseudomonas aeruginosa Bacterial infection Sharjah Institute for Medical Research AU
ST002730 AN004427 Multi-Omics profiling of Candida albicans from agar plate and suspension media Yeast cells Candida albicans University of Sharjah AU
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia intensity
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*min
ST000692 AN001070 Metabolites produced by strains associated with inflammation Bacterial cells Treponema Inflammation University of Michigan Peak area
ST000695 AN001076 Pilot metabolomics study of aromatase inhibitor associated arthralgias Blood Human Arthralgia University of Michigan Peak area
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002088 AN003407 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003411 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
  logo